Infection Prevention In Sarcoidosis: Proposal For Vaccination And Prophylactic Therapy

H. Syed; C. Ascoli; C.F.M. Linssen; C. Vagts; T. Iden; A. Syed; J. Kron; K. Polly; D. Perkins; P.W. Finn; R. Novak; M. Drent; R. Baughman; N.J. Sweiss

doi:10.36141/svdld.v37i2.9599

Infection Prevention In Sarcoidosis: Proposal For Vaccination And Prophylactic Therapy

H. Syed^*, C. Ascoli, C.F.M. Linssen, C. Vagts, T. Iden, A. Syed, J. Kron, K. Polly, D. Perkins, P.W. Finn, R. Novak, M. Drent, R. Baughman, N.J. Sweiss

^*Corresponding author for this work

Research output: Contribution to journal › (Systematic) Review article › peer-review

Abstract

Sarcoidosis is a systemic inflammatory disease characterized by granuloma formation in affected organs and caused by dysregulated immune response to an unknown antigen. Sarcoidosis patients receiving immunosuppressive medications are at increased risk of infection. Lymphopenia is also commonly seen among patient with sarcoidosis. In this review, risk of infections, including opportunistic infections, will be outlined. Recommendations for vaccinations and prophylactic therapy based on literature review will also be summarized.

Original language	English
Pages (from-to)	87-98
Number of pages	12
Journal	Sarcoidosis Vasculitis and Diffuse Lung Diseases
Volume	37
Issue number	2
DOIs	https://doi.org/10.36141/svdld.v37i2.9599
Publication status	Published - 1 Jan 2020

Keywords

sarcoidosis
infections
opportunistic infections
vaccinations
immunizations
prophylaxis
travel
progressive multifocal leukoencephalopathy
immunoglobulin replacement therapy
secondary antibody deficiency
long-term safety
rheumatoid-arthritis
herpes-zoster
serious infections
fungal-infections
1st manifestation
united-states
RHEUMATOID-ARTHRITIS
SECONDARY ANTIBODY DEFICIENCY
HERPES-ZOSTER
SERIOUS INFECTIONS
UNITED-STATES
Sarcoidosis
FUNGAL-INFECTIONS
1ST MANIFESTATION
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY
IMMUNOGLOBULIN REPLACEMENT THERAPY
LONG-TERM SAFETY

Access to Document

10.36141/svdld.v37i2.9599

Cite this

Syed, H., Ascoli, C., Linssen, C. F. M., Vagts, C., Iden, T., Syed, A., Kron, J., Polly, K., Perkins, D., Finn, P. W., Novak, R., Drent, M., Baughman, R., & Sweiss, N. J. (2020). Infection Prevention In Sarcoidosis: Proposal For Vaccination And Prophylactic Therapy. Sarcoidosis Vasculitis and Diffuse Lung Diseases, 37(2), 87-98. https://doi.org/10.36141/svdld.v37i2.9599

@article{de0070c258bc4be1baeb2d7483a8a1a3,

title = "Infection Prevention In Sarcoidosis: Proposal For Vaccination And Prophylactic Therapy",

abstract = "Sarcoidosis is a systemic inflammatory disease characterized by granuloma formation in affected organs and caused by dysregulated immune response to an unknown antigen. Sarcoidosis patients receiving immunosuppressive medications are at increased risk of infection. Lymphopenia is also commonly seen among patient with sarcoidosis. In this review, risk of infections, including opportunistic infections, will be outlined. Recommendations for vaccinations and prophylactic therapy based on literature review will also be summarized.",

keywords = "sarcoidosis, infections, opportunistic infections, vaccinations, immunizations, prophylaxis, travel, progressive multifocal leukoencephalopathy, immunoglobulin replacement therapy, secondary antibody deficiency, long-term safety, rheumatoid-arthritis, herpes-zoster, serious infections, fungal-infections, 1st manifestation, united-states, RHEUMATOID-ARTHRITIS, SECONDARY ANTIBODY DEFICIENCY, HERPES-ZOSTER, SERIOUS INFECTIONS, UNITED-STATES, Sarcoidosis, FUNGAL-INFECTIONS, 1ST MANIFESTATION, PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY, IMMUNOGLOBULIN REPLACEMENT THERAPY, LONG-TERM SAFETY",

author = "H. Syed and C. Ascoli and C.F.M. Linssen and C. Vagts and T. Iden and A. Syed and J. Kron and K. Polly and D. Perkins and P.W. Finn and R. Novak and M. Drent and R. Baughman and N.J. Sweiss",

note = "Publisher Copyright: {\textcopyright} Mattioli 1885.",

year = "2020",

month = jan,

day = "1",

doi = "10.36141/svdld.v37i2.9599",

language = "English",

volume = "37",

pages = "87--98",

journal = "Sarcoidosis Vasculitis and Diffuse Lung Diseases",

issn = "1124-0490",

publisher = "Mattioli 1885 S.p.A.",

number = "2",

}

TY - JOUR

T1 - Infection Prevention In Sarcoidosis: Proposal For Vaccination And Prophylactic Therapy

AU - Syed, H.

AU - Ascoli, C.

AU - Linssen, C.F.M.

AU - Vagts, C.

AU - Iden, T.

AU - Syed, A.

AU - Kron, J.

AU - Polly, K.

AU - Perkins, D.

AU - Finn, P.W.

AU - Novak, R.

AU - Drent, M.

AU - Baughman, R.

AU - Sweiss, N.J.

N1 - Publisher Copyright: © Mattioli 1885.

PY - 2020/1/1

Y1 - 2020/1/1

N2 - Sarcoidosis is a systemic inflammatory disease characterized by granuloma formation in affected organs and caused by dysregulated immune response to an unknown antigen. Sarcoidosis patients receiving immunosuppressive medications are at increased risk of infection. Lymphopenia is also commonly seen among patient with sarcoidosis. In this review, risk of infections, including opportunistic infections, will be outlined. Recommendations for vaccinations and prophylactic therapy based on literature review will also be summarized.

AB - Sarcoidosis is a systemic inflammatory disease characterized by granuloma formation in affected organs and caused by dysregulated immune response to an unknown antigen. Sarcoidosis patients receiving immunosuppressive medications are at increased risk of infection. Lymphopenia is also commonly seen among patient with sarcoidosis. In this review, risk of infections, including opportunistic infections, will be outlined. Recommendations for vaccinations and prophylactic therapy based on literature review will also be summarized.

KW - sarcoidosis

KW - infections

KW - opportunistic infections

KW - vaccinations

KW - immunizations

KW - prophylaxis

KW - travel

KW - progressive multifocal leukoencephalopathy

KW - immunoglobulin replacement therapy

KW - secondary antibody deficiency

KW - long-term safety

KW - rheumatoid-arthritis

KW - herpes-zoster

KW - serious infections

KW - fungal-infections

KW - 1st manifestation

KW - united-states

KW - RHEUMATOID-ARTHRITIS

KW - SECONDARY ANTIBODY DEFICIENCY

KW - HERPES-ZOSTER

KW - SERIOUS INFECTIONS

KW - UNITED-STATES

KW - Sarcoidosis

KW - FUNGAL-INFECTIONS

KW - 1ST MANIFESTATION

KW - PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY

KW - IMMUNOGLOBULIN REPLACEMENT THERAPY

KW - LONG-TERM SAFETY

U2 - 10.36141/svdld.v37i2.9599

DO - 10.36141/svdld.v37i2.9599

M3 - (Systematic) Review article

C2 - 33093774

SN - 1124-0490

VL - 37

SP - 87

EP - 98

JO - Sarcoidosis Vasculitis and Diffuse Lung Diseases

JF - Sarcoidosis Vasculitis and Diffuse Lung Diseases

IS - 2

ER -